# Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-dapagliflozin-as-a-treatment-for-chronic-kidney-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Phil McEwan,Oliver Darlington,Ryan Miller,John J.V. McMurray,David C. Wheeler,Hiddo J.L. Heerspink,Andrew Briggs,Klas Bergenheim,Juan José García Sánchez |
| Citations | 65 |
| DOI | 10.2215/cjn.03790322 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://research.rug.nl/en/publications/26bd027d-e6e1-4602-b2be-72b24357ae48 |
| OpenAlex ID | https://openalex.org/W4308060342 |
| PMID | 36323444 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Juan José García Sánchez](https://scholariq.org/researchers/juan-jose-garcia-sanchez/)

## Paper journal

- [Clinical Journal of the American Society of Nephrology](https://scholariq.org/journals/clinical-journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.